Innate Pharma (IPHA) P/E (2019 - 2026)
Innate Pharma (IPHA) P/E from Oct 17, 2019 to Jul 20, 2026. The TTM Innate Pharma (IPHA) P/E is -1.30. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Innate Pharma (IPHA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.30 | -3.23% |
| 2025 | -1.34 | -53.26% |
| 2024 | -2.87 | -9.32% |
| 2023 | -3.17 | -7.60% |
| 2022 | -3.43 | +31.55% |
| 2021 | -2.61 | -15.31% |
| 2020 | -3.08 | -104.20% |
| 2019 | 73.36 | N/A |
Comparison Innate Pharma (IPHA) P/E with competitors
Innate Pharma (IPHA) P/E is -1.30.